Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Two is better than one: drug synergy in relapsed/refractory NHL

Paul A. Hamlin • 29 Aug 2017
EHA 2017

Press brief by Paul A. Hamlin, MD from the Memorial Sloan Kettering Cancer Centre, New York, NY, USA at the European Hematology Association (EHA) 2017 meeting, held in Madrid, Spain.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals